Jackson Creek Investment Advisors LLC Kiniksa Pharmaceuticals, Ltd. Transaction History

Jackson Creek Investment Advisors LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 09, 2024	BUY	$17.63 - $21.74 $958,789 - $1.18 Million	54,384 New	54,384 $1.07 Million
Q3 2023 Nov 03, 2023	SELL	$13.62 - $20.2 $640 - $949	-47 Reduced 0.07%	65,607 $1.14 Million
Q2 2023 Aug 02, 2023	BUY	$10.44 - $16.48 $42,334 - $66,826	4,055 Added 6.58%	65,654 $924,000
Q1 2023 May 02, 2023	SELL	$10.7 - $15.79 $107 - $157	-10 Reduced 0.02%	61,599 $663,000
Q4 2022 Feb 03, 2023	BUY	$11.42 - $17.05 $703,574 - $1.05 Million	61,609 New	61,609 $923,000
Q2 2022 Aug 04, 2022	SELL	$7.6 - $11.41 $623,162 - $935,562	-81,995 Closed	0 $0
Q1 2022 May 03, 2022	BUY	$9.3 - $12.37 $45,811 - $60,934	4,926 Added 6.39%	81,995 $815,000
Q4 2021 Feb 01, 2022	BUY	$10.39 - $15.15 $800,746 - $1.17 Million	77,069 New	77,069 $907,000

1.95M

Ticker KNSA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 34,470,400
Market Cap $751M
Description
Kiniksa Pharmaceuticals, Ltd., a biopharmaceutical company, focuses on discovering, acquiring, developing, and commercializing therapeutic medicines for patients suffering from debilitating diseases with significant unmet medical needs worldwide. Its product candidates include ARCALYST, an interleukin-1alpha and interleukin-1beta, for the treatm...

Get notified when there are updates to the investment portfolio of Jackson Creek Investment Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Jackson Creek Investment Advisors LLC with notifications on news.